In addition to COX-derived products, cytochrome P450 monooxygenase-derived products contribute to lung cancer growth and progression and genetic and/or pharmacological inhibition of these enzymes prevents lung cancer development [17–19]. The gene discussed is CYP20A1; the disease is lung carcinoma.